NCT00117819View on ClinicalTrials.gov

A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Parkinsonian Syndrome
Interventions
DRUG

[123I]ß CIT and SPECT imaging

To assess \[123I\]ß CIT and SPECT imaging

Trial Locations (1)

06510

Institute for Neurodegenerative Disorders, New Haven

Sponsors

Collaborators (1)

Albany Medical College
All Listed Sponsors
collaborator

Indiana University

OTHER

collaborator

Albany Medical College

OTHER

lead

Institute for Neurodegenerative Disorders

OTHER